Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biologics in Leprosy: A Systematic Review and Case Report.
Cogen AL, Lebas E, De Barros B, Harnisch JP, Faber WR, Lockwood DN, Walker SL. Cogen AL, et al. Among authors: walker sl. Am J Trop Med Hyg. 2020 May;102(5):1131-1136. doi: 10.4269/ajtmh.19-0616. Am J Trop Med Hyg. 2020. PMID: 32157993 Free PMC article.
Leprosy.
Walker SL, Lockwood DN. Walker SL, et al. Clin Dermatol. 2007 Mar-Apr;25(2):165-72. doi: 10.1016/j.clindermatol.2006.05.012. Clin Dermatol. 2007. PMID: 17350495 Review.
Persistence of peri-neural granulomas after successful treatment of leprosy.
Ludwig RJ, Henke U, Wolter M, Walker SL, Brandt C, Wichelhaus TA, Kramme S, Lockwood DN, Kaufmann R. Ludwig RJ, et al. Among authors: walker sl. J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1414-6. doi: 10.1111/j.1468-3083.2007.02208.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17958851 No abstract available.
A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairment.
Walker SL, Nicholls PG, Dhakal S, Hawksworth RA, Macdonald M, Mahat K, Ruchal S, Hamal S, Hagge DA, Neupane KD, Lockwood DN. Walker SL, et al. PLoS Negl Trop Dis. 2011 Apr 12;5(4):e1041. doi: 10.1371/journal.pntd.0001041. PLoS Negl Trop Dis. 2011. PMID: 21532737 Free PMC article. Clinical Trial.
The effect of systemic corticosteroid therapy on the expression of toll-like receptor 2 and toll-like receptor 4 in the cutaneous lesions of leprosy Type 1 reactions.
Walker SL, Roberts CH, Atkinson SE, Khadge S, Macdonald M, Neupane KD, Ranjit C, Sapkota BR, Dhakal S, Hawksworth RA, Mahat K, Ruchal S, Hamal S, Hagge DA, Lockwood DN. Walker SL, et al. Br J Dermatol. 2012 Jul;167(1):29-35. doi: 10.1111/j.1365-2133.2012.10891.x. Epub 2012 Jun 1. Br J Dermatol. 2012. PMID: 22348338 Clinical Trial.
356 results